Economic Burdens of HCV Epidemic

In 2005, the estimated cost to provide health care for 100 patients with End Stage Liver Disease (ESLD), the most common result of untreated HCV, exceeded $9.9 million and over 3,670 hospital days. This cost reflects only the care in the last three to twelve months of their lives and does not include the three to five years prior comprised of  hospitalizations, surgeries, emergency room and outpatient visits, and prescription medications.

HCV infected individuals alone have the potential to severely impact public and private hospitals.